Burkina Faso ends Target Malaria, a GMO mosquito project funded by the Gates Foundation. The government cites biosafety risks, low impact, and scientific sovereignty in halting the program. The fight ...

Ugandan trial shows reduced efficacy of artemether-lumefantrine for malaria, with resistance mutations causing higher ...

The development of the new malaria medicine from the Basel-based pharmaceutical company Novartis for babies weighing 4½ to 11 pounds has given hope to many, with health workers in Nigeria, Congo and ...

Hesperos, the human-on-a-chip company, models the full life cycle of a deadly malaria parasite by combining a human ...

Until recently, a major gap in malaria treatment was how to care for newborns and infants infected with malaria who weren’t ...

The approval of Coartem Baby by Swiss regulators marks a breakthrough in malaria treatment for infants. This drug, tailored for babies weighing 2-5 kg, could significantly reduce malaria-related ...

Swiss medical regulators have approved a new malaria treatment for infants, offering hope to many in Africa KAMPALA, Uganda - ...

With children most at risk, African researchers believe genetically modified mosquitoes could save hundreds of thousands ...

A new generation of malaria drugs failed clinical trials, in part because they were hard to swallow. UCSF chemists remodeled their structures to make them more soluble, while maintaining their ...

The search for new ways to treat malaria—a disease that kills some 600,000 people a year, most of them children in Sub-Saharan Africa—may have just gotten a boost.